studied PVT1 expression as a biomarker of lymph node metastasis but found that when it was used instead as part of a biomarker group including PVT1, HOTTIP, and UCA1, the AUC was higher compared to its expression alone (75). The gene discussed is PVT1; the disease is metastatic malignant neoplasm in the lymph nodes.